Abstract
This study aimed to investigate the differences in the effects of spaceflight and ground environment on the metabolites of the tobramycin-resistant mutant strain of Escherichia coli (T1_13). A spaceflight-exposed tobramycin-resistant Escherichia coli strain (T1_13) in outer space for 64 days was labeled as the ST5, and the ground test group (GT5) was cultivated under the same conditions except for spaceflight. The metabolites in culture supernatant and precipitate of the ST5 and GT5 were identified by liquid chromatography-mass spectrometry (LC–MS). Compared with the GT5, a total of 83 different metabolites were identified in the supernatant of the ST5 (p < 0.05, FC ≥ 2 or p ≤ 0.5, VIP > 1), and 80 different metabolites were additionally identified in the precipitate of the ST5 (p < 0.05, FC ≥ 2 or p ≤ 0.5, VIP > 1). The results showed that spaceflight had a significant impact on different metabolic pathways. KEGG enrichment analysis indicated that the significantly enriched in the supernatant (S) were nicotinate and nicotinamide metabolism, aminobenzoate degradation, ABC transporters, metabolic pathways, and microbial metabolism in diverse environments. In addition, in the precipitate (C), toluene degradation, glycine, serine and threonine metabolism, pentose and glucuronate interconversions, cysteine and methionine metabolism, benzoate degradation, aminobenzoate degradation, microbial metabolism in diverse environments, 2-Oxocarboxylic acid metabolism and degradation of aromatic compounds were significantly enriched. Exploring metabolism characters of Escherichia coli would be helpful to further understand the physiological characteristics of tobramycin-resistant mutagenesis of Escherichia coli in outer space. This research will provide a basis for astronaut safety during spaceflight exposed to pathogenic bacteria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bijlani, S., Stephens, E., Singh, N.K., Venkateswaran, K., Wang, C.C.C.: Advances in Space Microbiology. Iscience. 24(5), 102395 (2021). https://doi.org/10.1016/j.isci.2021.102395
Burat, B., Gonzalez, J., Sauvage, F.L., Aouad, H., Arnion, H., Pinault, E., et al.: Sum of peak intensities outperforms peak area integration in iTRAQ protein expression measurement by LC-MS/MS using a TripleTOF 5600+ platform. Biosci. Rep. 39(6), (2019). https://doi.org/10.1042/bsr20190904
Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., et al.: MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic. Acids. Res. 46(W1), W486–W494 (2018). https://doi.org/10.1093/nar/gky310
Cui, L., Lu, H., Lee, Y.H.: Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Mass. Spectrom. Rev. 37(6), 772–792 (2018). https://doi.org/10.1002/mas.21562
Djebli, N., Martinez, J.M., Lohan, L., Khier, S., Brunet, A., Hurbin, F., et al.: Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies. Clin. Pharmacokinet. 56(10), 1155–1171 (2017). https://doi.org/10.1007/s40262-016-0505-1
Domnin, P.A., Parfenov, V.A., Kononikhin, A.S., Petrov, S.V., Shevlyagina, N.V., Arkhipova, A.Y., et al.: Combined Impact of Magnetic Force and Spaceflight Conditions on Escherichia coli Physiology. Int. J. Mol. Sci. 23(3), 1837 (2022). https://doi.org/10.3390/ijms23031837
Farkas, Á., Farkas, G.: Effects of Spaceflight on Human Skin. Skin. Pharmacol. Physiol. 34(5), 239–245 (2021). https://doi.org/10.1159/000515963
Gomes, T.A., Elias, W.P., Scaletsky, I.C., Guth, B.E., Rodrigues, J.F., Piazza, R.M., et al.: Diarrheagenic Escherichia coli. Braz. J. Microbiol. 47(Suppl 1), 3–30 (2016). https://doi.org/10.1016/j.bjm.2016.10.015
Huang, B., Li, D.G., Huang, Y., Liu, C.T.: Effects of spaceflight and simulated microgravity on microbial growth and secondary metabolism. Mil. Med. Res. 5(1), 18 (2018). https://doi.org/10.1186/s40779-018-0162-9
Karnovsky, A., Li, S.: Pathway Analysis for Targeted and Untargeted Metabolomics. Methods. Mol. Biol. 2104, 387–400 (2020). https://doi.org/10.1007/978-1-0716-0239-3_19
Li, X.Z., Li, H.M., Zhang, S.N., Liu, Q., Wang, Y.M.: A biolabel research based on metabonomics reveals the therapeutic potentials of Herba Lysimachiae in synovial diseases: The dual effects on synovial platelet aggregation by prostaglandin E1/E2. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 1174, 122726 (2021). https://doi.org/10.1016/j.jchromb.2021.122726
Mermel, L.A.: Infection prevention and control during prolonged human space travel. Clin. Infect. Dis. 56(1), 123–130 (2013). https://doi.org/10.1093/cid/cis861
Mhatre, S., Wood, J.M., Sielaff, A.C., Mora, M., Duller, S., Singh, N.K., et al.: Assessing the Risk of Transfer of Microorganisms at the International Space Station Due to Cargo Delivery by Commercial Resupply Vehicles. Front. Microbiol. 11, 566412 (2020). https://doi.org/10.3389/fmicb.2020.566412
Mingeot-Leclercq, M.P., Glupczynski, Y., Tulkens, P.M.: Aminoglycosides: activity and resistance. Antimicrob. Agents. Chemother. 43(4), 727–737 (1999). https://doi.org/10.1128/aac.43.4.727
Morrison, M.D., Thissen, J.B., Karouia, F., Mehta, S., Urbaniak, C., Venkateswaran, K., et al.: Investigation of Spaceflight Induced Changes to Astronaut Microbiomes. Front. Microbiol. 12, 659179 (2021). https://doi.org/10.3389/fmicb.2021.659179
Paitan, Y.: Current Trends in Antimicrobial Resistance of Escherichia coli. Curr. Top. Microbiol. Immunol. 416, 181–211 (2018). https://doi.org/10.1007/82_2018_110
Patejko, M., Jacyna, J., Markuszewski, M.J.: Sample preparation procedures utilized in microbial metabolomics: An overview. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 1043, 150–157 (2017). https://doi.org/10.1016/j.jchromb.2016.09.029
Poirel, L., Madec, J.Y., Lupo, A., Schink, A.K., Kieffer, N., Nordmann, P., et al.: Antimicrobial Resistance in Escherichia coli. Microbiol. Spectr. 6(4), (2018). https://doi.org/10.1128/microbiolspec.ARBA-0026-2017
Schrimpe-Rutledge, A.C., Codreanu, S.G., Sherrod, S.D., McLean, J.A.: Untargeted Metabolomics Strategies-Challenges and Emerging Directions. J. Am. Soc. Mass. Spectrom. 27(12), 1897–1905 (2016). https://doi.org/10.1007/s13361-016-1469-y
Sheet, S., Yesupatham, S., Ghosh, K., Choi, M.S., Shim, K.S., Lee, Y.S.: Modulatory effect of low-shear modeled microgravity on stress resistance, membrane lipid composition, virulence, and relevant gene expression in the food-borne pathogen Listeria monocytogenes. Enzyme. Microb. Technol. 133, 109440 (2020). https://doi.org/10.1016/j.enzmictec.2019.109440
Siddiqui, R., Akbar, N., Khan, N.A.: Gut microbiome and human health under the space environment. J. Appl. Microbiol. 130(1), 14–24 (2021). https://doi.org/10.1111/jam.14789
Stürchler, D.: Escherichia coli, a threat for babies, burgers and travelers. Travel. Med. Infect. Dis. 27, 139 (2019). https://doi.org/10.1016/j.tmaid.2019.01.009
Su, X., Guo, Y., Fang, T., Jiang, X., Wang, D., Li, D., et al.: Effects of Simulated Microgravity on the Physiology of Stenotrophomonas maltophilia and Multiomic Analysis. Front. Microbiol. 12, 701265 (2021). https://doi.org/10.3389/fmicb.2021.701265
Terbtothakun, P., Nwabor, O.F., Siriyong, T., Voravuthikunchai, S.P., Chusri, S.: Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) and bla(NDM-5). Antibiotics. 10(8), (2021). https://doi.org/10.3390/antibiotics10081023
Tirumalai, M.R., Karouia, F., Tran, Q., Stepanov, V.G., Bruce, R.J., Ott, C.M., et al.: The adaptation of Escherichia coli cells grown in simulated microgravity for an extended period is both phenotypic and genomic. NPJ. Microgravity. 3, 15 (2017). https://doi.org/10.1038/s41526-017-0020-1
Tirumalai, M.R., Karouia, F., Tran, Q., Stepanov, V.G., Bruce, R.J., Ott, C.M., et al.: Evaluation of Acquired Antibiotic Resistance in Escherichia coli Exposed to Long-Term Low-Shear Modeled Microgravity and Background Antibiotic Exposure. mBio. 10(1) (2019). https://doi.org/10.1128/mBio.02637-18
Tsugawa, H., Ikeda, K., Takahashi, M., Satoh, A., Mori, Y., Uchino, H., et al.: A lipidome atlas in MS-DIAL 4. Nat. Biotechnol. 38(10), 1159–1163 (2020). https://doi.org/10.1038/s41587-020-0531-2
Vachvanichsanong, P., McNeil, E.B., Dissaneewate, P.: Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections. Epidemiol. Infect. 149, e12 (2020). https://doi.org/10.1017/s0950268820003015
Venkateswaran, K., Vaishampayan, P., Cisneros, J., Pierson, D.L., Rogers, S.O., Perry, J.: International Space Station environmental microbiome - microbial inventories of ISS filter debris. Appl. Microbiol. Biotechnol. 98(14), 6453–6466 (2014). https://doi.org/10.1007/s00253-014-5650-6
Xie, C., Zhong, D., Yu, K., Chen, X.: Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS. Bioanalysis 4(8), 937–959 (2012). https://doi.org/10.4155/bio.12.43
Yim, J., Cho, S.W., Kim, B., Park, S., Han, Y.H., Seo, S.W.: Transcriptional Profiling of the Probiotic Escherichia coli Nissle 1917 Strain under Simulated Microgravity. Int. J. Mol. Sci. 21(8), (2020). https://doi.org/10.3390/ijms21082666
Yu, Y., Zhao, X., Guo, Y., Zhang, X., Bai, P., Zhang, B., et al.: Identification of potential tobramycin-resistant mutagenesis of Escherichia coli strains after spaceflight. Future. Microbiol. 14, 315–330 (2019). https://doi.org/10.2217/fmb-2018-0273
Yuan, M., Kremer, D.M., Huang, H., Breitkopf, S.B., Ben-Sahra, I., Manning, B.D., et al.: Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC-MS/MS. Nat. Protoc. 14(2), 313–330 (2019). https://doi.org/10.1038/s41596-018-0102-x
Zhang, X., Fang, X., Liu, C.: Genomic and Proteomic Analysis of Escherichia coli After Spaceflight Reveals Changes Involving Metabolic Pathways. Arch. Med. Res. 46(3), 181–185 (2015). https://doi.org/10.1016/j.arcmed.2015.03.007
Funding
This study was supported by funding from Chinese PLA General Hospital Youth Project (DC; No. QNF19074), the National Key Research and Development Program of China (SQ2021YFC2300197), and Beijing Nova Program Interdisciplinary Cooperation Project (DC; No. Z191100001119021).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
None of the co-authors reports any conflict of interest.
Competing Interest
The authors declare that there are no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xiaolei Su and Guangming Lu contributed equally.
Rights and permissions
About this article
Cite this article
Su, X., Lu, G., Zhou, X. et al. Space Environment Significantly Altered Metabolism in Tobramycin-resistant Mutagenesis of Escherichia coli Strain. Microgravity Sci. Technol. 34, 28 (2022). https://doi.org/10.1007/s12217-022-09952-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12217-022-09952-5